希腊基础生物医学研究所Mihalis Verykokakis、美国芝加哥大学Barbara L. Kee等研究人员合作发现，转录因子BCL6调控先天性T细胞的早期发育。相关论文于2020年7月27日在线发表在《自然—免疫学》杂志上。
Title: The transcription factor BCL-6 controls early development of innate-like T cells
Author: Marianthi Gioulbasani, Alexandros Galaras, Sofia Grammenoudi, Panagiotis Moulos, Alexander L. Dent, Mikael Sigvardsson, Pantelis Hatzis, Barbara L. Kee, Mihalis Verykokakis
Abstract: Innate T cells, including invariant natural killer T (iNKT) and mucosal-associated innate T (MAIT) cells, are a heterogeneous T lymphocyte population with effector properties preprogrammed during their thymic differentiation. How this program is initiated is currently unclear. Here, we show that the transcription factor BCL-6 was transiently expressed in iNKT cells upon exit from positive selection and was required for their proper development beyond stage 0. Notably, development of MAIT cells was also impaired in the absence of Bcl6. BCL-6-deficient iNKT cells had reduced expression of genes that were associated with the innate T cell lineage, including Zbtb16, which encodes PLZF, and PLZF-targeted genes. BCL-6 contributed to a chromatin accessibility landscape that was permissive for the expression of development-related genes and inhibitory for genes associated with naive T cell programs. Our results revealed new functions for BCL-6 and illuminated how this transcription factor controls early iNKT cell development.